Market CompetitionA steady stream of product rollouts, pricing negotiation conclusions, and market uptake for vamorolone is anticipated across Europe over 2025 and 2026.
Pricing PressuresSanthera continues to engage in pricing negotiations and reimbursement decisions across multiple key European territories, indicating steady progress and market uptake.
Reimbursement ChallengesThe €52K reimbursement level in Germany exceeds original expectations for European reimbursement, initially projected at only €40K per patient.